A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
CLARIANE SE operates in the Medical - Care Facilities industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 6.0B | 6.0B | 5.7B | 5.4B | 4.7B | 4.9B |
| Net Income | 1.8M | 1.8M | -60M | -101M | 33M | 133M |
| EPS | $0.00 | $0.00 | $-0.26 | $-1.07 | $0.14 | $0.83 |
| Free Cash Flow | 1.2B | 1.2B | 981M | 861M | 907M | 991M |
| ROIC | 6.4% | 3.3% | 2.1% | 1.1% | 1.8% | 2.6% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 1.06 | 1.07 | 2.00 | 2.00 | 2.15 |
| Dividends/Share | $0.20 | $0.20 | $0.24 | $0.76 | $0.41 | $0.33 |
| Operating Income | 340M | 340M | 283M | 177M | 287M | 403M |
| Operating Margin | 5.7% | 5.7% | 5.0% | 3.3% | 6.1% | 8.3% |
| ROE | 0.0% | 0.0% | -1.4% | -2.4% | 0.8% | 3.2% |
| Shares Outstanding | 399M | 399M | 230M | 94M | 149M | 130M |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 4.3B | 4.9B | 4.7B | 5.4B | 5.7B | 6.0B | 6.0B |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 305M | 403M | 287M | 177M | 283M | 340M | 340M |
| Op. Margin | 7.0% | 8.3% | 6.1% | 3.3% | 5.0% | 5.7% | 5.7% |
| Net Income | 48M | 133M | 33M | -101M | -60M | 1.8M | 1.8M |
| Net Margin | 1.1% | 2.7% | 0.7% | -1.9% | -1.0% | 0.0% | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||
| ROIC | 2.1% | 2.6% | 1.8% | 1.1% | 2.1% | 3.3% | 6.4% |
| ROE | 1.3% | 3.2% | 0.8% | -2.4% | -1.4% | 0.0% | 0.0% |
| ROA | 0.3% | 0.8% | 0.2% | -0.6% | -0.4% | 0.0% | 0.0% |
| Cash Flow | |||||||
| Op. Cash Flow | 913M | 991M | 907M | 861M | 981M | 1.2B | 1.2B |
| Free Cash Flow | 913M | 991M | 907M | 861M | 981M | 1.2B | 1.2B |
| Owner Earnings | 913M | 265M | 218M | 47M | 221M | 265M | 265M |
| CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 0 | 727M | 690M | 815M | 760M | 949M | 949M |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | N/A | 0 |
| D&A | 0 | 727M | 690M | 815M | 760M | 949M | 949M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||
| Dividends Paid | 12M | 43M | 61M | 71M | 55M | 79M | 79M |
| Dividend Yield | N/A | N/A | N/A | 13.6% | 11.1% | 4.5% | 5.3% |
| Share Buybacks | 905K | 3.0M | 6.8M | 535K | 140K | 181K | 181K |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.2% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 1.1B | 1.7B | 764M | 1.1B | 761M | 1.2B | 1.2B |
| Balance Sheet | |||||||
| Net Debt | 7.0B | 8.1B | 7.4B | 7.8B | 3.7B | 3.5B | -888M |
| Cash & Equiv. | 1.3B | 1.4B | 773M | 736M | 560M | 888M | 888M |
| Long-Term Debt | N/A | N/A | N/A | N/A | 3.2B | 3.7B | 3.7B |
| Debt/Equity | 2.19 | 2.15 | 2.00 | 2.00 | 1.07 | 1.06 | 0.00 |
| Interest Coverage | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | 3.8B | 4.4B | 4.1B | 4.3B | 4.0B | 4.1B | 4.1B |
| Total Assets | 15.2B | 16.9B | 15.3B | 16.5B | 15.4B | 15.6B | 15.6B |
| Total Liabilities | 11.3B | 12.4B | 11.3B | 12.2B | 11.4B | 11.5B | 11.5B |
| Intangibles | N/A | N/A | N/A | N/A | 2.5B | 2.4B | 2.4B |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital | N/A | -328M | -1.1B | N/A | N/A | N/A | N/A |
| Current Assets | N/A | 2.5B | 1.9B | 2.1B | N/A | N/A | N/A |
| Current Liabilities | N/A | 2.8B | 3.0B | N/A | N/A | N/A | N/A |
| Per Share Data | |||||||
| EPS | 0.34 | 0.83 | 0.14 | -1.07 | -0.26 | 0.00 | 0.00 |
| Owner EPS | 9.32 | 2.04 | 1.46 | 0.49 | 0.96 | 0.66 | 0.66 |
| Book Value | 38.93 | 34.23 | 27.29 | 45.46 | 17.37 | 10.26 | 10.26 |
| Cash Flow/Share | 9.32 | 7.64 | 6.08 | 9.16 | 4.27 | 3.04 | 2.38 |
| Dividends/Share | 0.12 | 0.33 | 0.41 | 0.76 | 0.24 | 0.20 | 0.20 |
| Shares Out. | 97.9M | 129.8M | 149.2M | 94.0M | 229.7M | 398.8M | 398.8M |
| Valuation | |||||||
| P/E Ratio | N/A | N/A | N/A | -2.5 | -8.2 | 986.4 | 827.3 |
| P/FCF | N/A | N/A | N/A | 0.3 | 0.5 | 1.5 | 1.2 |
| EV/EBIT | N/A | N/A | N/A | 45.4 | 14.9 | 15.4 | 1.8 |
| Price/Book | N/A | N/A | N/A | 0.1 | 0.1 | 0.4 | 0.4 |
| Price/Sales | N/A | N/A | N/A | 0.0 | 0.1 | 0.3 | 0.2 |
| FCF Yield | N/A | N/A | N/A | 344.6% | 200.8% | 68.2% | 81.3% |
| Market Cap | 0 | 0 | 0 | 250M | 489M | 1.8B | 1.5B |
| Avg. Price | 0.00 | 0.00 | 0.00 | 5.57 | 2.16 | 4.44 | 3.75 |
| Year-End Price | 0.00 | 0.00 | 0.00 | 2.66 | 2.13 | 4.47 | 3.75 |
CLARIANE SE passes 2 of 9 quality checks, indicating weak fundamentals.
CLARIANE SE trades at 832.4x trailing earnings, compared to its 15-year median P/E of 15.0x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 1.2x vs a median of 0.5x. The company's 5-year average ROIC is 2.2%. Total shareholder yield (dividends) is 5.3%. At current prices, the estimated annualized return to fair value is -18.9%.
CLARIANE SE (CLARI-PA) has a current P/E ratio of 832.4, compared to its historical median P/E of 15.0. The stock is currently considered Expensive based on its historical valuation range.
CLARIANE SE (CLARI-PA) has a 5-year average return on invested capital (ROIC) of 2.2%. This is below average and may indicate limited pricing power.
CLARIANE SE (CLARI-PA) has a market capitalization of $1.5B. It is classified as a small-cap stock.
Yes, CLARIANE SE (CLARI-PA) pays a dividend with a trailing twelve-month yield of 5.30%. The company also returns capital through share buybacks, with a buyback yield of 0.01%.
Based on historical P/E analysis, CLARIANE SE (CLARI-PA) appears expensive. The current P/E of 832.4 is 5450% above its historical median of 15.0.
CLARIANE SE (CLARI-PA) operates in the Medical - Care Facilities industry, within the Healthcare sector.
CLARIANE SE (CLARI-PA) reported annual revenue of $6.0 billion in its most recent fiscal year, based on SEC EDGAR filings.
CLARIANE SE (CLARI-PA) has a net profit margin of 0.0%. This is a modest margin.
CLARIANE SE (CLARI-PA) generated $1.2 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
CLARIANE SE (CLARI-PA) has a debt-to-equity ratio of 1.06. This indicates moderate leverage.
CLARIANE SE (CLARI-PA) reported earnings per share (EPS) of $0.00 in its most recent fiscal year.
CLARIANE SE (CLARI-PA) has a return on equity (ROE) of 0.0%. This indicates moderate shareholder returns.
The Ledger Terminal provides 6 years of financial data for CLARIANE SE (CLARI-PA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
CLARIANE SE (CLARI-PA) has a book value per share of $10.26, based on its most recent annual SEC filing.